Clinical Trials Logo

Marijuana Smoking clinical trials

View clinical trials related to Marijuana Smoking.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT03518567 Completed - Marijuana Smoking Clinical Trials

Behavioral Economic Analysis of Demand for Marijuana

Start date: October 15, 2018
Phase: Phase 2
Study type: Interventional

This laboratory study will employ a multi-session experimental design to examine the behavioral economic demand for marijuana, by studying effect of marijuana administration (High THC) on demand for marijuana, and marijuana smoking topography. The study will recruit 100 non-treatment seeking marijuana users who smoke marijuana at least twice weekly.

NCT ID: NCT01863095 Completed - Marijuana Smoking Clinical Trials

An Exercise App to Reduce Young Adults' MJ Use

Start date: October 2014
Phase: N/A
Study type: Interventional

Currently, marijuana (MJ) is the most popular illicit drug, but there are few effective interventions to help young adults (age 18 to 25 years) to reduce their MJ intake. In this study, we will develop and initially test a smart phone app designed to promote exercise/physical activity as a positive alternative to MJ use. The app will be tested in an efficacy study in which MJ users are randomly to either receive personalized feedback about MJ use + use the exercise app or personalized feedback only. The results will contribute to knowledge about exercise/physical activity as a strategy for reducing young adults' MJ use and problems.

NCT ID: NCT01536899 Completed - HIV Positive Clinical Trials

Medical Marijuana Use in HIV+ Patients Prospective Cohort Study

MMC-1
Start date: February 2012
Phase:
Study type: Observational

The investigators are interested in understanding personal factors such as medical conditions and mental health, as well as social and economic factors, that influence marijuana (and other substance) use in HIV-positive patients. Several alternative hypotheses will be evaluated in the proposed project: 1. healthier patients may self-select marijuana use; 2. marijuana use may be associated with consequences that create barriers to seeking healthcare; 3. marijuana use may have medicinal value that reduces the need for such care.

NCT ID: NCT01394185 Completed - Marijuana Smoking Clinical Trials

Effects of Dronabinol (Oral THC) on Cannabis Use

Start date: February 2011
Phase: Phase 1/Phase 2
Study type: Interventional

Study participants received dronabinol (0, 120mg/day and 240mg/day) for 12 consecutive days in a randomized order. During each dronabinol maintenance period they were able to self-administer active or placebo cannabis using either a progressive ratio schedule or choice between cannabis and monetary alternative.

NCT ID: NCT01081119 Completed - Alcohol Drinking Clinical Trials

Brief Voluntary Alcohol and Drug Intervention for Middle School Youth

CHOICE
Start date: September 2008
Phase: Phase 2
Study type: Interventional

We are currently working in 16 middle schools across Los Angeles, Santa Monica and Torrance to test out a voluntary after school program called Project CHOICE, which focuses on helping students decrease their alcohol and drug use. We are conducting surveys in all schools over three years and providing the intervention in 8 schools in the 2008-2009 school year and in the other 8 schools in the 2011-2012 school year. This is a program we have provided before in middle schools and we found that it was effective in curbing alcohol and drug use among students who voluntarily attended and among all students at the intervention school.

NCT ID: NCT01025700 Completed - Marijuana Smoking Clinical Trials

Nabilone & Marijuana Addiction

Start date: June 2009
Phase: Phase 2/Phase 3
Study type: Interventional

Safety of Nabilone in reducing marijuana craving

NCT ID: NCT00743366 Completed - Marijuana Smoking Clinical Trials

Effect of Quetiapine on Marijuana Withdrawal and Relapse

Start date: August 2008
Phase: Phase 2
Study type: Interventional

The objective of this study is to investigate the interaction between marijuana and quetiapine, with the goal of using this information to improve marijuana treatment outcome. It is hypothesized that quetiapine will decrease marijuana withdrawal and relapse. Primary outcome measures will be 1. marijuana's direct effects 2. marijuana withdrawal syndromes 3. marijuana relapse. It is also hypothesized that marijuana withdrawal will be associated with increased levels of stress hormones. A secondary measure will be salivary cortisol.

NCT ID: NCT00743145 Completed - Marijuana Smoking Clinical Trials

Effects of Low-dose Naltrexone in Combination With a Range of Smoked Marijuana

Start date: May 2008
Phase: Phase 2
Study type: Interventional

In heavy marijuana smokers, opioid receptor blockade increases the subjective and cardiovascular effects of marijuana. The current study was designed to clarify opioid-cannabinoid interactions by assessing how naltrexone shifts the dose-response function for marijuana-elicited effects in heavy marijuana smokers. For this within-subject, double-blind study, a marijuana smoking procedure was designed to characterize a dose-response relationship for marijuana's subjective and cardiovascular effects under blinded conditions.

NCT ID: NCT00650585 Completed - Smoking Clinical Trials

An Effectiveness Trial of Project ALERT

Start date: May 2004
Phase: N/A
Study type: Interventional

The purpose of this study is to replicate a longitudinal evaluation of Project ALERT, a substance abuse prevention program that targets middle school students.

NCT ID: NCT00506753 Completed - Alcohol Drinking Clinical Trials

Motivation and Skills for Delta-9-tetrahydrocannabinol/Ethanol (THC/ETOH+) Teens in Jail

SMART
Start date: September 2004
Phase: N/A
Study type: Interventional

This study will focus on treating substance abusing incarcerated teens using individually administered Motivational Interviewing (MI) followed by group Cognitive Behavior Therapy (CBT). The control group receives individualized Relaxation Training (RT) followed by group Treatment as Usual (TU). Currently, there is little research regarding effective group treatments for incarcerated teens and this study will address this gap in our knowledge base. We seek to reduce substance use and associated risky behaviors post-release (including driving under the influence, risky sexual behaviors, etc.)